Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeted Chemoprevention of Gastric Carcinogenesis in High Risk Populations

NCT02794428 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.

NCT NCT02794428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02794428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeted Chemoprevention of Gastric Carcinogenesis in High Risk Populations
Lead sponsor
Vanderbilt-Ingram Cancer Center
Phase
Phase 2
Overall status
Completed
Start date
September 19, 2016
Completion date
July 1, 2024
Enrollment
91 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, gastric intestinal metaplasia